Laekna Limited
Clinical trials sponsored by Laekna Limited, explained in plain language.
-
New obesity drug LAE103 enters first human safety trials
Disease control Recruiting nowThis early-stage study tests the safety and tolerability of a new injectable drug called LAE103 in healthy overweight or obese adults, and in healthy postmenopausal women. Researchers will also test LAE103 combined with another drug, LAE102. The goal is to find out if the drug is…
Phase: PHASE1 • Sponsor: Laekna Limited • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New Weight-Loss shot enters human testing
Disease control Recruiting nowThis early-stage trial is testing a new drug called LAE102, given as an injection, in healthy volunteers and people who are overweight or obese. The main goal is to check if the drug is safe and how the body processes it. Researchers will also look for early signs of weight-relat…
Phase: PHASE1 • Sponsor: Laekna Limited • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC